References
ElSohly MA (2002) Chemical constituents of cannabis. In: Grotenhermen F, Russo E (eds) Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential. Haworth, New York London Oxford, pp 27–36
ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Yi B, Banahan BF (2000) Potency trends of delta-9-THC and other cannabinoids in confiscated marijuana from 1980–1997. J Forens Sci 45:24–30
Joy JE, Watson SJ, Benson JA (eds) (1999) Marijuana and medicine: assessing the science base. National Academy Press, Washington D.C.
Kirk JM, Doty P, de Wit H (1998) Effects of expectancies on subjective responses to oral delta-9-tetrahydrocannabinol. Pharmacol Biochem Behav 59:287–293
Peck C, Coleman G (1991) Implications of placebo theory for clinical research and practice in pain management. Theor Med 12:247–270
Quitkin FM (1999) Placebos, drug effects and study design: a clinician's guide. Am J Psychiatry 156:829–836
Ross SA, ElSohly MA (1995) Constituents of Cannabis sativa L. XXVIII: a review of the natural constituents 1980–1994. Zagazig J Pharm Sci 4:1–10
Turner CE, Boeren EG, ElSohly MA (1980) Constituents of Cannabis sativa L. XVII: a review of the natural constituents 1980. Lloydia 43:169–171
Wachtel SR, ElSohly MA, Ross SA, de Wit H (2002) A comparison of the subjective effects of Δ9 tetrahydrocannabinol and marijuana in humans. Psychopharmacology 161:331–339
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
ElSohly, M.A., Wachtel, S.R. & de Wit, H. Cannabis versus THC: response to Russo and McPartland. Psychopharmacology 165, 433–434 (2003). https://doi.org/10.1007/s00213-002-1349-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-002-1349-y